Search Results for 'hiv tenofovir'

hiv tenofovir published presentations and documents on DocSlides.

The Bangkok Tenofovir Study
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
Switching the NRTI Backbone to Tenofovir DF-Emtricitabine
Switching the NRTI Backbone to Tenofovir DF-Emtricitabine
by reese
TOTEM. Switching the NRTI Backbone to Tenofovir DF...
HIV Pharmacotherapy Focused Update
HIV Pharmacotherapy Focused Update
by yoshiko-marsland
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
HIV Medication Overview
HIV Medication Overview
by kittie-lecroy
John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. A...
ART Initiation:  PrEP  and
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Conflict of Interest “No conflicts of interest to declare”
Conflict of Interest “No conflicts of interest to declare”
by karlyn-bohler
Lessons Learned from Tenofovir Vaginal Gel Studie...
Antiretroviral Updates:
Antiretroviral Updates:
by tatyana-admore
New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...
Switching from TDF/FTC to TAF/
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
Generic  tenofovir   disoproxil
Generic tenofovir disoproxil
by SunkissedBabe
fumarate and . emtricitabine. tablets obtained fr...
Major Changes to the HHS Adult and Adolescent HIV Treatment
Major Changes to the HHS Adult and Adolescent HIV Treatment
by tawny-fly
Brian R. Wood, MD. Assistant Professor of Medicin...
State
State
by pasty-toler
of the evidence from oral and topical . PrEP. ef...
Tenofovir
Tenofovir
by alida-meadow
based . PrEP. technologies in women : . what do...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Pre- and Post-Exposure Prophylaxis for HIV
Pre- and Post-Exposure Prophylaxis for HIV
by stefany-barnette
Kevin L. Ard, MD, MPH. October 20, 2016. Learning...
2014: HIV, HCV, and  HBV
2014: HIV, HCV, and HBV
by kittie-lecroy
Update. David Spach, MD. Professor of Medicine,...
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
by Powerpixel
Clinical Pharmacist – HIV Medicine. Outline. Wha...
HIV in Flux Viruses We’re talking tiny: 110 – 150 nm
HIV in Flux Viruses We’re talking tiny: 110 – 150 nm
by TacoBellDiego
That’s 150 billionths of a meter. The bad guy . ...
HIV  OI's and  prophylaxis
HIV OI's and prophylaxis
by callie
, PEP, PREP . Compiled by Jason Vermaak, . Ektha. ...
HIV Pharmacotherapy Focused Update
HIV Pharmacotherapy Focused Update
by sherrill-nordquist
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
by jade
Madeline Droney, PharmD. In it for the Long-Haul. ...
HBV Clinical Management [TRAINER(S) NAME(S)]
HBV Clinical Management [TRAINER(S) NAME(S)]
by mia
IAPAC African Regional . Capacity-Building . Hub. ...
Getting the  FACTS Right!
Getting the FACTS Right!
by sophie
Update & Scenario Planning for FACTS001 Trial....
HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional
HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional
by mitsue-stanley
HBV Clinical Management [TRAINER(S) NAME(S)] IAPA...
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
by briana-ranney
B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...
W orking
W orking
by min-jolicoeur
with . Different Groups. Module 3 (f). People who...
Managing Antiretroviral Failure in 2012
Managing Antiretroviral Failure in 2012
by sherrill-nordquist
Jennifer Hoy. , MBBS. Professor of Medicine. Dire...
New Prevention Technologies Workshop
New Prevention Technologies Workshop
by olivia-moreira
Module 5: . State of NPT Research. www.icad-cisd....
Projecting  the Impact of
Projecting the Impact of
by marina-yarberry
Generic. HIV . Drugs. on 90-90-90. Esteban Burr...
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N
by briana-ranney
Guidelines for Prevention and Treatment of Opport...
ACTHIV 2018:  A State-of-the-Science Conference for Frontline Health Professionals
ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
by phoebe-click
ACTIVITY CODE . TD342. Antiretroviral Medications...
TENOFOVIR ALAFENAMIDE PHARMACOKINETICS
TENOFOVIR ALAFENAMIDE PHARMACOKINETICS
by studyne
WITH AND WITHOUT COBICISTAT IN PREGNANCY . Jeremia...
The goal of hepatitis C virus (HCV) treatment is a cure (when there is
The goal of hepatitis C virus (HCV) treatment is a cure (when there is
by amey
Genotype 1, never treated for HCV, no cirrhosis12 ...
Tenofovir   Alafenamide  (TAF)
Tenofovir Alafenamide (TAF)
by nicole
in a Single-Tablet Regimen . in Initial HIV-1 Ther...
Switching From a  Tenofovir
Switching From a Tenofovir
by yael
. Disoproxil. . Fumarate. (TDF)-Based Regimen to...
Cases from the Clinic(ians):  Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...